Neoplastic Disease Clinical Trials in Linz
2 recruitingLinz, Austria
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
GlioblastomaNeoplastic DiseaseGlioblastoma (GBM)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited50 enrolled4 locationsNCT07100730
Recruiting
Phase 1
131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
GlioblastomaGlioblastoma MultiformeNeoplastic Disease
Telix Pharmaceuticals (Innovations) Pty Limited12 enrolled6 locationsNCT05450744